文献速递脑血管病

法国VECTOR随机单盲试验:支架取栓器联合接触抽吸与单纯接触抽吸治疗急性前循环缺血性卒中伴磁敏感血管征阳性的安全性和有效性

Safety and efficacy of stent retrievers plus contact aspiration in patients with acute ischaemic anterior circulation stroke and positive susceptibility vessel sign in France (VECTOR): a randomised, single-blind trial.
PubMed 文献 · Lancet Neurol · 2024-01-01

VECTOR研究为法国22中心前瞻性随机开放标签盲法评估试验,纳入526例磁敏感血管征(SVS)阳性的急性前循环缺血性卒中患者,比较支架取栓器联合接触抽吸与单纯接触抽吸作为一线取栓技术的安全性和有效性。主要结局(≤3次pass后eTICI 2c-3再灌注)两组无显著差异(58% vs 52%,OR 1.27,95%CI 0.88-1.83,p=0.19)。作者认为结果不支持联合技术优于单纯抽吸,支持两者均可作为初始取栓策略。

要点

  • SVS阳性前循环卒中患者中,联合技术组eTICI 2c-3再灌注58%,单纯抽吸组52%,差异无统计学意义(OR 1.27,95%CI 0.88-1.83,p=0.19)。
  • 操作相关不良事件联合技术组12% vs 单纯抽吸组11%(OR 1.14,95%CI 0.65-2.00,p=0.65)。
  • 3个月全因死亡率联合技术组23% vs 单纯抽吸组19%(OR 1.19,95%CI 0.76-1.86,p=0.45),均与治疗无关。

核心结论

  • VECTOR试验结果未显示支架取栓器联合接触抽吸技术相较于单纯接触抽吸在SVS阳性闭塞患者中实现≤3次pass后eTICI 2c-3再灌注方面具有优效性。
  • 这些发现支持将联合技术或单纯接触抽吸作为急性前循环卒中伴治疗前MRI显示SVS患者的初始取栓策略。

研究设计与样本

  • VECTOR为前瞻性、随机、开放标签、盲法评估研究,在法国22个中心纳入治疗前MRI显示前循环SVS阳性闭塞且症状发作24小时内动脉穿刺的患者。
  • 由介入神经放射科医师通过基于网络的集中化方法进行最小化动态随机,患者按1:1随机分配至联合技术组或单纯接触抽吸组。
  • 主要结局为治疗后血管造影上≤3次pass后eTICI 2c或3级再灌注,由盲法独立中央影像核心实验室裁定。
  • 意向治疗人群用于评估主要和次要结局,试验注册号ClinicalTrials.gov NCT04139486,已完成。

主要发现

  • 2019年11月26日至2022年2月14日共纳入526例患者,其中521例构成意向治疗人群(联合技术组n=263,单纯接触抽吸组n=258)。
  • 参与者中位年龄74.9岁(IQR 64.4-83.3),女性284例(55%),男性237例(45%)。
  • 主要结局两组无显著差异:联合技术组152/263例(58%)vs 单纯接触抽吸组135/258例(52%)(OR 1.27,95%CI 0.88-1.83,p=0.19)。
  • 操作相关不良事件:联合技术组32/263例(12%)vs 单纯接触抽吸组27/257例(11%)(OR 1.14,95%CI 0.65-2.00,p=0.65)。
  • 最常见不良事件为脑出血:联合技术组146/259例(56%)vs 单纯接触抽吸组123/251例(49%)(OR 1.32,95%CI 0.91-1.90,p=0.13)。

临床怎么用

  • 作者认为,对于治疗前MRI显示SVS的急性前循环卒中患者,这些发现支持将联合技术或单纯接触抽吸作为初始取栓策略。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Positive susceptibility vessel sign (SVS) in patients with acute ischaemic stroke has been associated with friable red blood cell-rich clots and more effective recanalisation using stent retrievers versus contact aspiration. We compared the safety and efficacy of stent retrievers plus contact aspiration (combined technique) versus contact aspiration alone as the first-line thrombectomy technique in patients with acute ischaemic anterior circulation stroke and SVS-positive occlusions. METHODS: Adaptive Endovascular Strategy to the Clot MRI in Large Intracranial Vessel Occlusion (VECTOR) was a prospective, randomised, open-label study with blinded evaluation. Patients with SVS-positive anterior circulation occlusions on pretreatment MRI and arterial puncture within 24 h of symptom onset were enrolled from 22 centres in France. A centralised web-based method was used by interventional neuroradiologists for dynamic randomisation by minimisation. Patients were randomly assigned 1:1 to the combined technique or contact aspiration alone. The primary outcome was expanded Thrombolysis in Cerebral Infarction (eTICI) grade 2c or 3 reperfusion after three or fewer passes on post-treatment angiogram, adjudicated by a blinded independent central imaging core laboratory. The intention-to-treat population was used to assess the primary and secondary outcomes. This trial is registered with ClinicalTrials.gov (NCT04139486) and is complete. FINDINGS: Between Nov 26, 2019, and Feb 14, 2022, 526 patients were enrolled, of whom 521 constituted the intention-to-treat population (combined technique, n=263; contact aspiration alone, n=258). The median age of participants was 74·9 years (IQR 64·4-83·3); 284 (55%) were female and 237 (45%) male. The primary outcome did not differ significantly between groups (152 [58%] of 263 patients for the combined technique vs 135 [52%] of 258 for contact aspiration; odds ratio [OR] 1·27; 95% CI 0·88-1·83; p=0·19). Procedure-related adverse events occurred in 32 (12%) of 263 patients in the combined technique group and 27 (11%) of 257 in the contact aspiration group (OR 1·14; 0·65-2·00; p=0·65). The most common adverse event was intracerebral haemorrhage (146 [56%] of 259 patients for the combined technique vs 123 [49%] of 251 for contact aspiration; OR 1·32; 0·91-1·90; p=0·13). All-cause mortality at 3 months occurred in 57 (23%) of 251 patients in the combined technique group and 48 (19%) of 247 in the contact aspiration group (OR 1·19; 0·76-1·86; p=0·45), none of which was treatment-related. INTERPRETATION: The results of the VECTOR trial do not show superiority of the combined stent retriever plus contact aspiration technique over contact aspiration alone in patients with SVS-positive occlusion with respect to achieving eTICI 2c-3 within three passes. These findings support the use of either the combined technique or contact aspiration alone as the initial thrombectomy strategy in patients with acute anterior circulation stroke with SVS on pretreatment MRI. FUNDING: Cerenovus.

来源:Lancet Neurol,查看原文。版权归原作者所有。

引用

  1. Bourcier R, Marnat G, Dargazanli C, et al. Safety and efficacy of stent retrievers plus contact aspiration in patients with acute ischaemic anterior circulation stroke and positive susceptibility vessel sign in France (VECTOR): a randomised, single-blind trial. Lancet Neurol. 2024. PMID: 38876748. doi:10.1016/S1474-4422(24)00165-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。